Development of a Novel Yeast Cell-Based System for Studying the Aggregation of Alzheimer’s Disease-Associated Aβ Peptides in vivo

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Neurodegenerative Diseases

• Publication date

  2007-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000101838PMID 17596708
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The [PSI+] prion of yeast: a problem of inheritance.

  2006cited by this paper
• Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).

  2006cited by this paper
• Biochemical and genetic methods for characterization of [PIN+] prions in yeast.

  2006cited by this paper
• Modulation of Prion Formation, Aggregation, and Toxicity by the Actin Cytoskeleton in Yeast

  2006cited by this paper
• α-Synuclein Targets the Plasma Membrane via the Secretory Pathway and Induces Toxicity in Yeast

  2005cited by this paper
• Polypeptide chain termination and stop codon readthrough on eukaryotic ribosomes

  2005cited by this paper
• The aggregation kinetics of Alzheimer's β‐amyloid peptide is controlled by stochastic nucleation

  2005cited by this paper
• Chaperoning prions: the cellular machinery for propagating an infectious protein?

  2005cited by this paper
• Yeast growth selection system for the identification of cell-active inhibitors of beta-secretase.

  2004cited by this paper
• Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro.

  2004cited by this paper
• Dissection and Design of Yeast Prions

  2004cited by this paper
• Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits

  2004cited by this paper
• Conformational variations in an infectious protein determine prion strain differences

  2004cited by this paper
• Protein-only transmission of three yeast prion strains

  2004cited by this paper
• Prion domain interaction responsible for species discrimination in yeast [PSI+] transmission

  2003cited by this paper
• Yeast [PSI+] Prion Aggregates Are Formed by Small Sup35 Polymers Fragmented by Hsp104*

  2003cited by this paper
• Global analysis of protein expression in yeast

  2003cited by this paper
• Intracellular translation initiation factor levels in Saccharomyces cerevisiae and their role in cap‐complex function

  2002cited by this paper
• Guanidine Hydrochloride Inhibits the Generation of Prion “Seeds” but Not Prion Protein Aggregation in Yeast

  2002cited by this paper
• The SUP 35 Omnipotent Suppressor Gene Is Involved in the Maintenance of the Non-Mendelian Determinant [ psi ' ] in the Yeast Saccharomyces cerevisiae

  2002cited by this paper
• Amyloid aggregates of the HET-s prion protein are infectious

  2002cited by this paper
• Changes in the middle region of Sup35 profoundly alter the nature of epigenetic inheritance for the yeast prion [PSI+]

  2002cited by this paper
• Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method.

  2002cited by this paper
• The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.

  2001cited by this paper
• The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation

  2001cited by this paper
• Prions affect the appearance of other prions: the story of [PIN(+)].

  2001cited by this paper
• Protein-based inheritance in Saccharomyces cerevisiae: [URE3] as a prion form of the nitrogen regulatory protein Ure2.

  2001cited by this paper
• The elimination of the yeast [PSI+] prion by guanidine hydrochloride is the result of Hsp104 inactivation

  2001cited by this paper
• Oligopeptide repeats in the yeast protein Sup35p stabilize intermolecular prion interactions

  2001cited by this paper
• Strains of [PSI+] are distinguished by their efficiencies of prion‐mediated conformational conversion

  2001cited by this paper
• Guanidine hydrochloride blocks a critical step in the propagation of the prion-like determinant [PSI(+)] of Saccharomyces cerevisiae.

  2000cited by this paper
• Rapid and reliable protein extraction from yeast

  2000cited by this paper
• Creating a protein-based element of inheritance.

  2000cited by this paper
• Generation of the Amyloid-β Peptide N Terminus inSaccharomyces cerevisiae Expressing Human Alzheimer's Amyloid-β Precursor Protein*

  1999cited by this paper
• Oxygen Stress: A Regulator of Apoptosis in Yeast

  1999cited by this paper
• Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments.

  1997cited by this paper
• The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog.

  1997cited by this paper
• Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae.

  1996cited by this paper
• Potassium Deprivation-Induced Apoptosis of Cerebellar Granule Neurons: A Sequential Requirement for New mRNA and Protein Synthesis, ICE-Like Protease Activity, and Reactive Oxygen Species

  1996cited by this paper
• Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

  1996cited by this paper
• Support for the Prion Hypothesis for Inheritance of a Phenotypic Trait in Yeast

  1996cited by this paper
• Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein.

  1996cited by this paper
• Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

  1996cited by this paper
• Propagation of the yeast prion‐like [psi+] determinant is mediated by oligomerization of the SUP35‐encoded polypeptide chain release factor.

  1996cited by this paper
• A new efficient gene disruption cassette for repeated use in budding yeast

  1996cited by this paper
• Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+].

  1995cited by this paper
• The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae.

  1994cited by this paper
• Multicopy SUP35 gene induces de-novo appearance of psi-like factors in the yeast Saccharomyces cerevisiae

  1993cited by this paper
• The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.

  1993cited by this paper
• Attempts to restore scrapie prion infectivity after exposure to protein denaturants.

  1993cited by this paper
• Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension.

  1989cited by this paper
• 5-Fluoroorotic acid as a selective agent in yeast molecular genetics.

  1987cited by this paper
• Agents that cause a high frequency of genetic change from [psi+] to [psi-] in Saccharomyces cerevisiae.

  1981cited by this paper
• Reversion from suppression to nonsuppression in SUQ5 [psi+] strains of yeast: the classificaion of mutations.

  1980cited by this paper
• Ψ, A cytoplasmic suppressor of super-suppressor in yeast

  1965cited by this paper

• Yeast as a Model for Human Disease.

  2026cites this paper
• Exogenous prion-like proteins and their potential to trigger cognitive dysfunction

  2025cites this paper
• Alzheimer’s Disease: Significant Benefit from the Yeast-Based Models

  2023cites this paper
• Animal models of Alzheimer’s disease: Applications, evaluation, and perspectives

  2022cites this paper
• Microbial Pathogenesis and Pathophysiology of Alzheimer's Disease: A Systematic Assessment of Microorganisms' Implications in the Neurodegenerative Disease

  2021cites this paper
• Application of yeast to studying amyloid and prion diseases.

  2020cites this paper
• Flavonoid-Derived Human Phenyl-γ-Valerolactone Metabolites Selectively Detoxify Amyloid-β Oligomers and Prevent Memory Impairment in a Mouse Model of Alzheimer's Disease.

  2020cites this paper
• From Cell Entry to Engraftment of Exogenous Mitochondria

  2020cites this paper
• Yeast contributions to Alzheimer’s Disease

  2020cites this paper
• Elucidating the Molecular Determinants of Aβ Aggregation with Deep Mutational Scanning

  2019cites this paper
• Hundreds of yeast mRNAs form a separately addressable, translation elongation-controlled regulon

  2019cites this paper
• Yeast Models for the Study of Amyloid-Associated Disorders and Development of Future Therapy

  2019cites this paper
• Proteome-Scale Mapping of Perturbed Proteostasis in Living Cells.

  2019cites this paper
• On translational control by ribosome speed in S. cerevisiae

  2019cites this paper
• Yeast Models for Amyloids and Prions: Environmental Modulation and Drug Discovery

  2019cites this paper
• Yeast models of neurodegenerative diseases.

  2019cites this paper
• Recent Insights on Alzheimer’s Disease Originating from Yeast Models

  2018cites this paper
• Interplay of Energetics and ER Stress Exacerbates Alzheimer's Amyloid-β (Aβ) Toxicity in Yeast

  2017cites this paper
• Human TorsinA can function in the yeast cytosol as a molecular chaperone

  2017cites this paper
• Inhibition of Aβ42 oligomerization in yeast by a PICALM ortholog and certain FDA approved drugs

  2016cites this paper
• Engineered bacterial hydrophobic oligopeptide repeats in a synthetic yeast prion, [REP-PSI+]

  2015cites this paper
• Yeast Model of Amyloid-β and Tau Aggregation in Alzheimer’s Disease

  2015cites this paper
• Yeast as a platform for identification of chemo-protectors of Alzheimer's disease

  2015cites this paper
• Protein Aggregation in Unicellular Eukaryotes

  2014cites this paper
• Yeast models for amyloid disease.

  2014cites this paper
• Application of Yeast to Study the Tau and Amyloid-β Abnormalities of Alzheimer's Disease

  2013cites this paper
• Harnessing the power of yeast to unravel the molecular basis of neurodegeneration

  2013cites this paper
• A yeast model for amyloid-β aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity

  2012cites this paper
• Modelling neurodegeneration in S . cerevisiae : Why cook with Baker ’ s yeast ?

  2012cites this paper
• Oxidative Stress in Alzheimer's and Parkinson's Diseases: Insights from the Yeast Saccharomyces cerevisiae

  2012cites this paper
• Probing the role of structural features of mouse PrP in yeast by expression as Sup35-PrP fusions

  2012cites this paper
• Yeast as a model system to study genetic and post-translational regulation of metabolic pathways in mammals

  2012cites this paper
• Yeast as a Model for Studying A Aggregation, Toxicity and Clearance

  2011cites this paper
• [Yeast as a model for studying neurodegeneration].

  2011cites this paper
• Drożdże jako model w badaniach chorób neurodegeneracyjnych* Yeast as a model for studying neurodegeneration

  2011cites this paper
• Yeast as a model for studying neurodegeneration

  2011cites this paper
• Biodiscovery of chemo preventatives of Alzheimer’s disease using yeast

  2010cites this paper
• Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker's yeast?

  2010cites this paper
• Structure and function of the molecular chaperone Hsp104 from yeast.

  2010cites this paper
• Yeast as a model for studying Alzheimer's disease.

  2010cites this paper
• Nervous yeast: modeling neurotoxic cell death.

  2010cites this paper
• Decoding accuracy in eRF1 mutants and its correlation with pleiotropic quantitative traits in yeast

  2010cites this paper
• Oxidative stress in yeast

  2010cites this paper
• Ribosome-associated peroxiredoxins suppress oxidative stress–induced de novo formation of the [PSI+] prion in yeast

  2010cites this paper
• Protein glycation and methylglyoxal metabolism in Parkinson's disease

  2009cites this paper
• Protein aggregation as a paradigm of aging.

  2009cites this paper
• Recent advances of research on the [PSI+] prion in Saccharomyces cerevisiae

  2008cites this paper
• Protein folding diseases and neurodegeneration: lessons learned from yeast.

  2008cites this paper
• Hsp104 targets multiple intermediates on the amyloid pathway and suppresses the seeding capacity of Abeta fibrils and protofibrils.

  2008cites this paper
• Yeast as a model for studying human neurodegenerative disorders

  2008cites this paper
• Study of cellular responses and protein interactions of Abeta in yeast models

  2008cites this paper